Results 31 to 40 of about 57,485 (298)
This systematic review and meta-analysis examined the optimal trough concentration of voriconazole for adult patients with invasive fungal infections. We used stepwise cutoffs of 0.5–2.0 μg/mL for efficacy and 3.0–6.0 μg/mL for safety.
Yuki Hanai +8 more
doaj +1 more source
BackgroundErlotinib is presently the first line treatment for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) active mutation.
Dehua Liao +10 more
doaj +1 more source
Background: Linezolid-induced thrombocytopenia (LIT) is the main factor limiting the clinical application of linezolid (LZD). The incidence and risk factors of LIT in neonatal patients were possibly different from other populations based on ...
Lufen Duan +12 more
doaj +1 more source
He+ dominance in the plasmasphere during geomagnetically disturbed periods: 1. Observational results [PDF]
Observations made by the DMSP 1710 satellite during the recovery phase from geomagnetic disturbances in June 1991 show regions of He+ dominance around 830 km altitude at 09:00 MLT.
Wilford, C. R. +13 more
core +1 more source
High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction
Afatinib is used to treat non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutation as a second-generation EGFR-tyrosine kinase inhibitor (TKI).
Takayuki Takahashi +11 more
core +1 more source
Objective: Continuous lenalidomide (LEN) therapy is important to achieve a therapeutic effect in patients with multiple myeloma (MM) and non-Hodgkin lymphoma (NHL).
Zaiwei Song +18 more
doaj +1 more source
Posaconazole trough concentrations are not influenced by inflammation: A prospective study
During inflammation, several cytochrome P450 enzymes are downregulated. Recently it was shown that voriconazole metabolism is reduced during inflammation. Posaconazole, another triazole with broad-spectrum antifungal activity, is metabolised only to a limited extent by cytochrome P450 enzymes and to a wider extent by phase 2 enzyme systems.
Märtson, Anne-Grete +7 more
openaire +2 more sources
Small molecule kinase inhibitors (SMKIs) are widely used in oncology. Therapeutic drug monitoring (TDM) for SMKIs could reduce underexposure or overexposure.
Ruben A. G. van Eerden +4 more
doaj +1 more source
Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir
PURPOSE: Triple therapy for HCV-1 infection consists in boceprevir or telaprevir, ribavirin and PEG-interferon. Telaprevir is a P-glycoprotein substrate and it is metabolized by CYP3A4/5. No data have been published on intracellular penetration of telaprevir.
CUSATO, JESSICA +8 more
openaire +4 more sources
Objective: To examine the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit (ICU) and to analyze the factors influencing the trough concentration.
Xiaodan Qian +4 more
doaj +1 more source

